Home
CIBMTR (Center for International Bloo...

十一月 2025的CIBMTR (Center for Inter...市场份额分析

the center for international blood and marrow transplant research (cibmtr) is a collaborative resource of data and experts supporting research in cellular therapies to improve patient outcomes.

健康 > 医药

域cibmtr.org

成立年份2004

员工51 - 200

年营收--

CIBMTR (Center for International Bloo...

CIBMTR (Center for International Bloo...（包含公司地区分支机构）

cibmtr.org

查看更多网站流量和参与度信息

CIBMTR (Center for International Bloo...热门域名的总访问量

了解CIBMTR (Center for International Bloo...市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

cibmtr.org12.7K

使用销售情报查看更多信息

CIBMTR (Center for International Bloo...热门域名的平均访问时长

分析CIBMTR (Center for International Bloo...参与度指标。

过去 3 个月的平均访问时长

子公司明细

cibmtr.org00:00:52

使用销售情报查看更多信息

CIBMTR (Center for International Bloo...热门域名的平均页面浏览量

了解CIBMTR (Center for International Bloo...如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

cibmtr.org2.08

使用销售情报查看更多信息

CIBMTR (Center for International Bloo... 排名靠前的竞争对手（按域名）

十一月 2025的热门相似网站，按亲和力排名

hematology.org公司名称American Society of Hematology员工51 - 200总部美国, 哥伦比亚特区, Washington年营收$50M - $75M总访问量663.2K健康 > 医药

CIBMTR (Center for International Bloo... 采用的主要技术

这些是排名前 CIBMTR (Center for International Bloo... 的顶级域名所使用的网站技术（按行业分列）

付款和货币 (22)

PayPal

转化和分析 (4)

Google Analytics

内容管理系统 (3)

Kentico

小部件 (2)

reCAPTCHA

更多技术

12

查看全部

CIBMTR (Center for International Bloo... 的新闻与信号

借助 Similarweb 销售信号提醒，每当在目标受众之中出现新的机会或威胁时，您都会收到所识别出购买信号的每日更新。

新闻Center for International Blood and Marrow Transplant Research hired Kwang Woo Ahn as Chief Statistical Director on Sep 1st '24.The Medical College of Wisconsin is pleased to announce that Dr. Kwang Woo Ahn has been appointed Chief Statistical Director of the CIBMTR, effective September 1, 2024.

新闻Center for International Blood and Marrow Transplant Research launched chimeric antigen receptor T cell therapy on Mar 22nd '22.Recently, the CIBMTR expanded to include data for other cell therapies, such as chimeric antigen receptor T cell (CAR-T) therapy.

新闻Emmes Corporation partners with Center for International Blood and Marrow Transplant Research.Emmes has partnered with the Center for International Blood and Marrow Transplant Research (CIBMTR) and NMDP/Be The Match to develop and implement a study enrolling patients and collecting samples to determine how these immunocompromised patients respond to the COVID-19 vaccines.